Risks of Opioids in ST-Elevation Myocardial Infarction: A Review
Anne Henrieke Tavenier (),
Renicus Suffridus Hermanides,
Jan Paul Ottervanger,
Peter Gerrit Johannes Horst,
Elvin Kedhi and
Adriaan W. J. Hof
Additional contact information
Anne Henrieke Tavenier: Isala
Renicus Suffridus Hermanides: Isala
Jan Paul Ottervanger: Isala
Peter Gerrit Johannes Horst: Isala
Elvin Kedhi: Isala
Adriaan W. J. Hof: Maastricht University Medical Center
Drug Safety, 2018, vol. 41, issue 12, No 4, 1303-1308
Abstract:
Abstract Although opioids are recommended and frequently used in the acute phase of ST-elevation myocardial infarction (STEMI), their use is accompanied by serious side effects. In particular, gastrointestinal adverse effects may disturb absorption of essential oral medication like platelet inhibitors. This may cause suboptimal platelet inhibition and increased risk of acute stent thrombosis. Some clinical studies have already demonstrated these negative results. Alternative strategies to optimize platelet inhibition and pain relief in STEMI are being investigated. Clinicians should become more aware of the potential side effects of opioids in STEMI.
Date: 2018
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s40264-018-0710-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0710-y
Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264
DOI: 10.1007/s40264-018-0710-y
Access Statistics for this article
Drug Safety is currently edited by Nitin Joshi
More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().